MIRIAM ROUMIEH: Open Payments
NPI 1679326490 · ROCHESTER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 1 | $145 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $102 |
Products named: QUTENZA, PYRUKYND, REXULTI, EPIDIOLEX, VOQUEZNA, Auvelity.
Industry payments across MI — which companies pay providers there.
